Kolexia
Dubray-Longeras Pascale
Oncologie médicale
Centre Jean-Perrin
Clermont-Ferrand, France
138 Activités
209 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Sarcomes Tumeurs du sein Carcinome pulmonaire à petites cellules Tumeurs du poumon Carcinome pulmonaire non à petites cellules Récidive tumorale locale Tumeurs du sein triple-négatives Métastase tumorale Tumeurs des tissus mous

Industries

B3TSI
52 collaboration(s)
Dernière en 2023
MSD
16 collaboration(s)
Dernière en 2023
AstraZeneca
15 collaboration(s)
Dernière en 2023
Lilly
7 collaboration(s)
Dernière en 2023

Dernières activités

CHIC-STS01: Interest of Peri Operative CHemotherapy In Patients With CINSARC High-risk Localized Soft Tissue Sarcoma
Essai Clinique (Institut Universitaire du Cancer Toulouse Oncopole)   26 février 2024
The efficacy of immune checkpoint inhibitors following discontinuation for long-term response or toxicity in advanced or metastatic non-small-cell lung cancers: A retrospective study.
Health science reports   25 janvier 2024
Improved nationwide survival of sarcoma patients with a network of reference centers.
Annals of oncology : official journal of the European Society for Medical Oncology   19 janvier 2024
NIRVANA-LUNG: PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in Advanced Non-small Cell Lung Cancer
Essai Clinique (Unicancer)   11 décembre 2023
Sclerosing Epithelioid Fibrosarcoma (SEF) versus Low Grade Fibromyxoid Sarcoma (LGFMS): Presentation and outcome in the nationwide NETSARC+ series of 330 patients over 13 years.
European journal of cancer (Oxford, England : 1990)   23 novembre 2023
First-line real-world treatment patterns and survival outcomes in women younger or older than 40 years with metastatic breast cancer in the real-life multicenter French ESME cohort.
European journal of cancer (Oxford, England : 1990)   10 novembre 2023
FLASH: A Randomized Study to Investigate the Efficacy and Safety of the Tumor-targeting Human Antibody-cytokine Fusion Protein L19TNF in Previously Treated Patients With Advanced Stage or Metastatic Soft-tissue Sarcoma
Essai Clinique (Philogen S.p.A.)   05 octobre 2023
1401P Impact of KRAS mutation on non-small cell lung cancer survival outcomes
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
1928P Differential presentation and outcome of sclerosing epithelioid fibrosarcoma (SEF) vs low grade fibromyxoid sarcoma (LGFMS): The nationwide series of 330 patients in NETSARC since 2010
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
1927P Epithelioid hemangio-endothelioma (EHE) in NETSARC: The nationwide series of 267 patients over 12 years
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023